HIV and Hepatitis.com Coverage of the
42
nd EASL Conference
April 11 - 15, 2007, Barcelona, Spain
THE EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER


HIV-HCV Coinfection Articles

Body Fat Changes in HIV-HCV Coinfected Men and Women

Influence of Antiretroviral Drugs on Liver Fibrosis Progression in HIV-HCV Coinfected Patients

Influence of Antiretroviral Drugs on Liver Fibrosis Progression in HIV-HCV Coinfected Patients

Mutations That Confer Resistance to HCV Protease Inhibitors

Genetic Variation Predicts Poor Treatment Response in HIV-HCV Coinfected Patients

High Rate of Liver-Related Mortality among HIV Positive Persons in France

Role of HIV Coinfection in Mortality Related to Hepatitis B or C

AZT Can Cause Severe Anemia and Necessitate Ribavirin Dose Reduction in HIV-HCV Coinfected Patients

Spontaneous HCV Clearance Is Uncommon among HIV Positive Individuals, but Treatment Is Effective

HIV-HCV Coinfected Patients with Normal CD4 Counts Do Not Have More Rapid Liver Fibrosis Progression

 













 

 

 

 

















HOME